However, administration of propranolol, a β-adrenergic receptor blocker, but not RU486, a glucocorticoid receptor blocker, into post-stroke mice have been shown to reduce bacterial complications and mortality after stroke, strongly suggesting a role catecholamines in inducing immune suppression post-stroke [85]. Here, NR3C1 is linked to stroke disorder.